ABOUT TKG VENTURESPORTFOLIO

TKG

Portfolio

PINETREE Therapeutics

A biotech company developing next-generation therapeutics based on its proprietary targeted protein degradation (TPD) platform, "AbRaptor"

Go to homepage
Galux

Development of AI-based new drug design platform

Go to homepage
Cellarkbio Co.,Ltd.

Develops and produces next-generation Dermal Fillers based on cell regeneration mechanisms

Go to homepage
INGENIA Therapeutics

Development of Therapeutic Agents for Vascular Diseases Related to Microvascular Abnormalities.

Go to homepage
ExoCoBio

ExoCoBio develops exosome-based biomedicine for regenerative aesthetics. They hit dramatic sales records with ASCE+ stimulation and have dominated technical product positioning.

Go to homepage